Mylan Launches Generic Actonel
Actonel is a bisphosphonate indicated for the treatment and prevention of osteoporosis in postmenopausal women. Actonel has an affinity for hydroxyapatite crystals in bone and acts as an antiresoprtive agent. At the cellular level, Actonel inhibits osteoclasts. The osteoclasts adhere normally to the bone surface, but show evidence of reduced active resorption.
Risedronate Tablets are available in a 150mg strength and shipment has begun for this product.
For more information call (800) RX-MYLAN or visit Mylan.com.